TAK Biopharma IVS: Financial statements 2017
CVR: 37962872
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
TAK Biopharma IVS (CVR 37962872) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 80,322 and a net result of DKK -23,344. The profit margin was -29.1%. Equity in the 2017 report amounted to DKK -186,754.
- Revenue
- DKK 80,322
- Gross Profit
- DKK 66,528
- Profit/Loss
- DKK -23,344
- Equity
- DKK -186,754
- Total Assets
- DKK 868
Official annual report
Keep an eye on TAK Biopharma IVS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
TAK Biopharma IVS has published its interim report for the period August 26, 2016 to December 31, 2016.
About TAK Biopharma IVS
TAK Biopharma IVS was a Danish company of the type Iværksætterselskab based in København N, founded in 2016. The company has been dissolved on 20 June 2021. The company was registered under the industry Fremstilling af farmaceutiske råvarer. The company has 1 employee (2020). In 2019, the company reported revenue of DKK 379,951 and a net result of DKK -22,190 compared with DKK 149,224 the year before. Equity in the 2019 report amounted to DKK -59,720.